Table 3 Clinical assessment before and after intervention in each group
Variables | Rehabilitation (n = 30) | P-value | Control (n = 30) | P-value | ||
|---|---|---|---|---|---|---|
| Â | Pre | Post | Â | Pre | Post | Â |
|  | Mean ± SD | Mean ± SD |  | Mean ± SD | Mean ± SD |  |
Chalder fatigue | 19.3 ± 2.3 | 11.1 ± 0.94 |  < 0.001*(PT) | 18.9 ± 2.5 | 13.4 ± 2.1 |  < 0.001*(PT) |
6MWT | 270.7 ± 34.7 | 439.7 ± 25.3 |  < 0.001*(PT) | 274.1 ± 31.8 | 347 ± 32.7 |  < 0.001*(PT) |
PFI | 17.7 ± 3.7 | 52.3 ± 10.3 |  < 0.001*(PT) | 17.2 ± 3.5 | 36.7 ± 4.2 |  < 0.001*(PT) |
SF-36 Questionnaire | ||||||
Total score | 16.4 ± 1.7 | 66.4 ± 3.7 |  < 0.001*(PT) | 17.6 ± 3.4 ±  | 47.6 ± 2.6 ±  |  < 0.001*(PT) |
mMRC | N. (%) | N. (%) | P-value | N. (%) | N. (%) | P-value |
|---|---|---|---|---|---|---|
No (0) | – | 3 (10%) |  < 0.001*(C) | – | 0 (0%) |  < 0.001*(C) |
Mild (1) | – | 19 (63.3%) | – | 11 (36.7%) | ||
Moderate (2) | 9 (30%) | 8 (26.7%) | 8 (26.7%) | 19 (63.3%) | ||
Severe (3) | 21 (70%) | – | 22 (73.3%) | – |